4.7 Article

MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma

Journal

CANCER LETTERS
Volume 375, Issue 1, Pages 73-83

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2016.02.043

Keywords

Hepatocellular carcinoma; Focal adhesion kinase; Invasion; Metastasis; miR-379-5p

Categories

Funding

  1. National Natural Science Foundation of China [81201930, 81572424, 81472253, 81472258]
  2. Research Fund for the Doctoral Program of Higher Education of China [20124423120006]
  3. Natural Science Foundation of Guangdong Province [S2012040006803, 2014A030313063]
  4. Key Project of Guangzhou Municipal Science & Technology Planning [2011J4100053]
  5. Doctoral Research Foundation of Guangzhou Medical University [2010C23]

Ask authors/readers for more resources

Some microRNAs (miRNAs) have been implicated in hepatocellular carcinoma (HCC) development and progression. However, the roles and mechanisms of several miRNAs in HCC remain poorly understood. Here, we report that miR-379-5p, which is down-regulated in HCC tissues and cell lines, is associated with advanced TNM stage and metastasis in HCC. The ectopic overexpression of miR-379-5p inhibited HCC cell migration, invasion, epithelial-to-mesenchymal transition (EMT) and metastasis both in vitro and in vivo. Conversely, miR-379 knockdown increased migration, invasion and EMT in HCC cells. Moreover, miR-379-5p exerted this function by directly targeting focal adhesion kinase (FAK) 3'-UTR and repressing FAK expression, thus leading to suppression of AKT signaling. Furthermore, the tumor suppressive effects of miR-379-5p in HCC cells were reversed by activating AKT signaling or restoring FAK expression. In clinical samples of HCC, miR-379-5p negatively correlated with FAK, which was up regulated in HCC. Taken together, our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling, suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available